 Shares of Arbutus Biopharma Corp. ABUS, 7.21 gained 11.0 in premarket trading on Monday after the company said it is suing Moderna Inc. MRNA, 1.70 for infringing on several patents that relate to Modernas COVID-19 vaccine. Arbutus filed the lawsuit with Genevant Sciences Corp., a privately held company. 